Private Trust Company’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.86M | Sell |
8,440
-692
| -8% | -$191K | 0.15% | 142 |
|
|
2026
Q1 | $2.7M | Sell |
9,132
-234
| -2% | -$69.5K | 0.24% | 81 |
|
|
2025
Q4 | $2.56M | Buy |
9,366
+409
| +5% | +$111K | 0.22% | 88 |
|
|
2025
Q3 | $2.42M | Sell |
8,957
-160
| -2% | -$43.5K | 0.21% | 100 |
|
|
2025
Q2 | $2.51M | Buy |
9,117
+5,295
| +139% | +$1.44M | 0.24% | 87 |
|
|
2025
Q1 | $1.01M | Buy |
3,822
+280
| +8% | +$69.1K | 0.1% | 217 |
|
|
2024
Q4 | $823K | Buy |
3,542
+110
| +3% | +$25.3K | 0.08% | 260 |
|
|
2024
Q3 | $757K | Sell |
3,432
-224
| -6% | -$46.4K | 0.08% | 288 |
|
|
2024
Q2 | $719K | Buy |
3,656
+408
| +13% | +$84.3K | 0.08% | 284 |
|
|
2024
Q1 | $699K | Sell |
3,248
-28
| -0.9% | -$5.88K | 0.08% | 289 |
|
|
2023
Q4 | $690K | Buy |
3,276
+129
| +4% | +$27.5K | 0.08% | 270 |
|
|
2023
Q3 | $630K | Buy |
3,147
+408
| +15% | +$81.1K | 0.08% | 270 |
|
|
2023
Q2 | $508K | Buy |
2,739
+407
| +17% | +$75.2K | 0.06% | 314 |
|
|
2023
Q1 | $447K | Buy |
2,332
+1,469
| +170% | +$266K | 0.06% | 329 |
|
|
2022
Q4 | $145K | Buy |
863
+61
| +8% | +$10.6K | 0.02% | 610 |
|
|
2022
Q3 | $142K | Sell |
802
-152
| -16% | -$30K | 0.02% | 564 |
|
|
2022
Q2 | $195K | Sell |
954
-12
| -1% | -$2.54K | 0.03% | 493 |
|
|
2022
Q1 | $230K | Sell |
966
-231
| -19% | -$54.3K | 0.04% | 322 |
|
|
2021
Q4 | $273K | Sell |
1,197
-127
| -10% | -$27.9K | 0.04% | 338 |
|
|
2021
Q3 | $256K | Sell |
1,324
-57
| -4% | -$11.5K | 0.04% | 361 |
|
|
2021
Q2 | $293K | Buy |
1,381
+34
| +3% | +$7.18K | 0.04% | 339 |
|
|
2021
Q1 | $274K | Buy |
1,347
+120
| +10% | +$23.6K | 0.04% | 347 |
|
|
2020
Q4 | $223K | Buy |
+1,227
| New | +$209K | 0.04% | 348 |
|
|
2020
Q3 | – | Sell |
-1,460
| Closed | -$241K | – | 360 |
|
|
2020
Q2 | $241K | Buy |
1,460
+130
| +10% | +$23.3K | 0.05% | 312 |
|
|
2020
Q1 | $229K | Buy |
1,330
+212
| +19% | +$42.2K | 0.06% | 301 |
|
|
2019
Q4 | $224K | Buy |
+1,118
| New | +$229K | 0.04% | 357 |
|
|
2019
Q2 | – | Sell |
-1,445
| Closed | -$237K | – | 374 |
|
|
2019
Q1 | $237K | Sell |
1,445
-2,043
| -59% | -$361K | 0.05% | 327 |
|
|
2018
Q4 | $656K | Buy |
3,488
+66
| +2% | +$12.2K | 0.16% | 159 |
|
|
2018
Q3 | $582K | Buy |
3,422
+2,008
| +142% | +$338K | 0.12% | 211 |
|
|
2018
Q2 | $231K | Buy |
+1,414
| New | +$231K | 0.05% | 339 |
|
|
2014
Q4 | – | Sell |
-675
| Closed | -$54K | – | 459 |
|
|
2014
Q3 | $54K | Sell |
675
-1,350
| -67% | -$102K | 0.02% | 527 |
|
|
2014
Q2 | $144K | Sell |
2,025
-31
| -2% | -$2.18K | 0.05% | 342 |
|
|
2014
Q1 | $152K | Buy |
2,056
+1,529
| +290% | +$115K | 0.06% | 289 |
|
|
2013
Q4 | $41K | Hold |
527
| – | – | 0.02% | 490 |
|
|
2013
Q3 | $39K | Buy |
527
+270
| +105% | +$19.9K | 0.02% | 478 |
|
|
2013
Q2 | $20K | Buy |
+257
| New | +$16.9K | 0.01% | 625 |
|
Other funds holding CME
Private Trust Company's CME Position: Q2 2026 in Review
Private Trust Company reduced its CME Group (CME) stake by 7.6% in Q2 2026, selling an estimated $191K and leaving 8,440 shares worth $1.86M. The position accounts for 0.15% of the portfolio, ranked #142.
Private Trust Company first reported a position in CME in Q2 2013 and has held it in 36 quarters since. The position peaked at $2.7M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Private Trust Company held 8,440 shares of CME Group worth $1.86M as of Q2 2026.
- Private Trust Company sold 692 CME Group shares in Q2 2026, an estimated $191K.
- CME Group made up 0.15% of Private Trust Company's portfolio in Q2 2026, its #142 holding.
- Private Trust Company first reported a position in CME Group in Q2 2013 and has held it in 36 quarters since.
- Private Trust Company's CME Group position peaked at $2.7M in Q1 2026.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.